Annexin Pharmaceuticals Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Wichtige Informationen
46.9%
Wachstumsrate der Gewinne
n/a
EPS-Wachstumsrate
Pharmaceuticals Gewinnwachstum | 54.4% |
Wachstumsrate der Einnahmen | 178.1% |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 15 Apr 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2025 | 40 | -17 | N/A | N/A | 1 |
12/31/2024 | N/A | -52 | N/A | N/A | 1 |
3/31/2024 | N/A | -46 | -45 | -45 | N/A |
12/31/2023 | N/A | -44 | -43 | -43 | N/A |
9/30/2023 | N/A | -40 | -43 | -43 | N/A |
6/30/2023 | N/A | -38 | -40 | -40 | N/A |
3/31/2023 | N/A | -41 | -43 | -43 | N/A |
12/31/2022 | N/A | -41 | -41 | -41 | N/A |
9/30/2022 | N/A | -47 | -39 | -39 | N/A |
6/30/2022 | N/A | -45 | -39 | -39 | N/A |
3/31/2022 | N/A | -43 | -40 | -40 | N/A |
12/31/2021 | N/A | -52 | -45 | -45 | N/A |
9/30/2021 | N/A | -53 | -47 | -47 | N/A |
6/30/2021 | N/A | -53 | -48 | -48 | N/A |
3/31/2021 | N/A | -55 | -48 | -48 | N/A |
12/31/2020 | N/A | -44 | -39 | -39 | N/A |
9/30/2020 | N/A | -38 | -34 | -34 | N/A |
6/30/2020 | N/A | -36 | -30 | -30 | N/A |
3/31/2020 | N/A | -31 | -24 | -24 | N/A |
12/31/2019 | N/A | -28 | -26 | -26 | N/A |
9/30/2019 | N/A | -25 | -24 | -24 | N/A |
6/30/2019 | N/A | -24 | -26 | -26 | N/A |
3/31/2019 | N/A | -25 | -27 | -27 | N/A |
12/31/2018 | N/A | -29 | -29 | -29 | N/A |
9/30/2018 | N/A | -31 | -33 | -33 | N/A |
6/30/2018 | N/A | -30 | -36 | -35 | N/A |
3/31/2018 | N/A | -32 | -39 | -39 | N/A |
12/31/2017 | N/A | -31 | N/A | -39 | N/A |
9/30/2017 | N/A | -25 | N/A | -36 | N/A |
6/30/2017 | N/A | -26 | N/A | -29 | N/A |
3/31/2017 | N/A | -17 | N/A | -18 | N/A |
12/31/2016 | N/A | -10 | N/A | -10 | N/A |
12/31/2015 | N/A | -5 | N/A | -5 | N/A |